We refer to recent media speculation in respect of Volaris Group’s non-binding indicative proposal (NBIO) to acquire all of the shares in EROAD that we do not currently own in the company. In particular, we note the speculation in media outlets relating to Volaris Group being poised to lift our NBIO price.
As is public knowledge, on 12 July 2023, the board of EROAD rejected Volaris Group’s NBIO and declined to progress the NBIO.
In response to the media speculation, Volaris Group wishes to clarify that it currently has no intention to increase its proposal price under its NBIO, although it reserves its right to do so if there is a change of circumstances (including, but not limited to, being granted access to due diligence by EROAD).
- END -